Victory Capital Management
NUVB icon

Victory Capital Management’s Nuvation Bio NUVB Stock Holding History

Victory Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$162K Buy
28,570
+688
+2% +$3.36K ﹤0.01% 2290
2026
Q1 		$120K Buy
27,882
+319
+1% +$1.78K ﹤0.01% 2259
2025
Q4 		$247K Buy
27,563
+1,044
+4% +$6.47K ﹤0.01% 2154
2025
Q3 		$98.1K Sell
26,519
-520
-2% -$1.42K ﹤0.01% 2296
2025
Q2 		$52.7K Sell
27,039
-315
-1% -$656 ﹤0.01% 2376
2025
Q1 		$48.1K Sell
27,354
-985
-3% -$2.24K ﹤0.01% 2369
2024
Q4 		$75.4K Buy
28,339
+7,441
+36% +$19.2K ﹤0.01% 2356
2024
Q3 		$47.9K Sell
20,898
-297
-1% -$906 ﹤0.01% 2395
2024
Q2 		$61.9K Buy
21,195
+2,349
+12% +$7.17K ﹤0.01% 2346
2024
Q1 		$68.6K Sell
18,846
-528
-3% -$1.01K ﹤0.01% 2349
2023
Q4 		$29.3K Buy
19,374
+3,494
+22% +$4.5K ﹤0.01% 2481
2023
Q3 		$21.3K Buy
15,880
+408
+3% +$679 ﹤0.01% 2444
2023
Q2 		$27.9K Sell
15,472
-361
-2% -$614 ﹤0.01% 2431
2023
Q1 		$26.3K Buy
15,833
+300
+2% +$608 ﹤0.01% 2491
2022
Q4 		$29.8K Sell
15,533
-7
-0% -$14 ﹤0.01% 2491
2022
Q3 		$35K Buy
+15,540
New +$44.4K ﹤0.01% 2591
2022
Q1 		– Sell
-179,245
Closed -$1.52M – 2789
2021
Q4 		$1.52M Sell
179,245
-21,860
-11% -$201K ﹤0.01% 1652
2021
Q3 		$2M Sell
201,105
-1,580
-0.8% -$14.3K ﹤0.01% 1606
2021
Q2 		$1.89M Hold
202,685
– – ﹤0.01% 1651
2021
Q1 		$2.12M Buy
+202,685
New +$2.27M ﹤0.01% 1637

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Victory Capital Management's NUVB Position: Q2 2026 in Review

Victory Capital Management increased its Nuvation Bio (NUVB) stake by 2.5% in Q2 2026, buying an estimated $3.36K and bringing the position to 28,570 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #2290.

Victory Capital Management first reported a position in NUVB in Q1 2021 and has held it in 20 quarters since. The position peaked at $2.12M in Q1 2021. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Victory Capital Management held 28,570 shares of Nuvation Bio worth $162K as of Q2 2026.
  • Victory Capital Management bought 688 Nuvation Bio shares in Q2 2026, an estimated $3.36K.
  • Nuvation Bio made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2290 holding.
  • Victory Capital Management first reported a position in Nuvation Bio in Q1 2021 and has held it in 20 quarters since.
  • Victory Capital Management's Nuvation Bio position peaked at $2.12M in Q1 2021.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.